Dr. Nkiruka Ezenwajiaku

Claim this profile

University of Miami Miller School of Medicine-Sylvester Cancer Center

Studies Pancreatic Cancer
Studies Adenocarcinoma
2 reported clinical trials
5 drugs studied

Area of expertise

1Pancreatic Cancer
Nkiruka Ezenwajiaku has run 2 trials for Pancreatic Cancer. Some of their research focus areas include:
Stage IV
BRCA1 positive
BRCA2 positive
2Adenocarcinoma
Nkiruka Ezenwajiaku has run 2 trials for Adenocarcinoma. Some of their research focus areas include:
Stage IV
BRCA1 positive
BRCA2 positive

Affiliated Hospitals

Image of trial facility.
University Of Miami Miller School Of Medicine-Sylvester Cancer Center
Image of trial facility.
UM Sylvester Comprehensive Cancer Center At Plantation

Clinical Trials Nkiruka Ezenwajiaku is currently running

Image of trial facility.

Olaparib

for Pancreatic Cancer

This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting0 awards Phase 232 criteria

More about Nkiruka Ezenwajiaku

Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Nkiruka Ezenwajiaku has experience with
  • Anetumab Ravtansine
  • Gemcitabine Hydrochloride
  • Ipilimumab
  • Nivolumab
  • Olaparib
Breakdown of trials Nkiruka Ezenwajiaku has run
Pancreatic Cancer
Adenocarcinoma
Pancreatic Adenocarcinoma
Cancer
Adenosquamous Carcinoma

Other Doctors you might be interested in

Frances Valdes-Albini, MDUniversity of Miami
Benjamin Spieler, MDUniversity of Miami
Alvaro J. AlencarUniversity of Miami-Sylvester Cancer Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nkiruka Ezenwajiaku specialize in?
Nkiruka Ezenwajiaku focuses on Pancreatic Cancer and Adenocarcinoma. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Nkiruka Ezenwajiaku currently recruiting for clinical trials?
Yes, Nkiruka Ezenwajiaku is currently recruiting for 1 clinical trial in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Nkiruka Ezenwajiaku has studied deeply?
Yes, Nkiruka Ezenwajiaku has studied treatments such as Anetumab Ravtansine, Gemcitabine Hydrochloride, Ipilimumab.
What is the best way to schedule an appointment with Nkiruka Ezenwajiaku?
Apply for one of the trials that Nkiruka Ezenwajiaku is conducting.
What is the office address of Nkiruka Ezenwajiaku?
The office of Nkiruka Ezenwajiaku is located at: University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida 33136 United States. This is the address for their practice at the University of Miami Miller School of Medicine-Sylvester Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top